Combining ESG with Semaglutide or Tirzepatide for Medical Weight Loss

Author: Dr. Shapsis
Khrom MedSpa And Weight Loss

Doctors Explain Why Combining ESG with GLP-1 Medications Is Changing Medical Weight Loss

Endoscopic Sleeve Gastroplasty (ESG) can be combined with GLP-1 weight-loss medications such as semaglutide (Ozempic®, Wegovy®) or tirzepatide (Mounjaro®, Zepbound®) to enhance weight loss and improve long-term metabolic control. ESG reduces stomach volume and helps patients feel full sooner, while GLP-1 medications reduce appetite and regulate blood sugar. When used together under medical supervision, these treatments can support stronger and more sustained fat loss than either option alone.

Key Takeaways

🟢 ESG reduces stomach size without surgery
🟢 GLP-1 medications help control appetite and metabolism
🟢 Combining both approaches may improve weight-loss outcomes
🟢 Medical supervision helps maintain long-term results

What Is ESG Combined With GLP-1 Medication?

Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive procedure that reduces stomach capacity using an endoscope inserted through the mouth. The stomach is sutured from the inside to create a sleeve-like shape, which limits food intake and promotes earlier fullness.

GLP-1 medications such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) act on hormonal pathways involved in appetite regulation and glucose metabolism. These medications slow gastric emptying, reduce hunger signals, and improve insulin sensitivity.

Some physicians recommend combining ESG with GLP-1 therapy. The procedure addresses stomach capacity, while medication targets appetite regulation and metabolic control.

Why It Happens

Weight loss is influenced by both mechanical and hormonal factors. ESG physically reduces the volume of food the stomach can hold. GLP-1 medications influence brain signals that control hunger and satiety.

When both mechanisms work together, patients often experience stronger appetite control and better adherence to a reduced-calorie diet.

What Causes Weight Regain After Bariatric Procedures?

Many patients who undergo weight-loss procedures experience gradual weight regain over time. Hormonal adaptation and appetite signals can change after significant weight loss.

How It Develops

After weight reduction, the body may increase hunger hormones and reduce energy expenditure. Patients may also adapt to smaller stomach capacity over time.

GLP-1 medications can help address these biological signals by reducing appetite and improving metabolic regulation. For some patients, doctors recommend adding medication months or years after a procedure to support continued weight control.

Symptoms or Signs of Ineffective Weight Control

People who struggle with obesity or weight regain may experience several patterns:

• persistent hunger even after meals
• slow or stalled weight loss
• gradual regain of lost weight
• difficulty maintaining calorie restriction

These patterns often reflect hormonal signals involved in appetite regulation.

How Doctors Recognize It

Doctors evaluate several factors before recommending a combined approach. These include body mass index (BMI), weight-loss history, metabolic health, and previous bariatric procedures.

Blood sugar levels, insulin resistance, and liver function may also influence treatment decisions.

Treatment or Prevention Options

Treatment plans vary depending on a patient’s medical history and weight-loss goals.

Endoscopic Sleeve Gastroplasty reduces stomach size without external incisions. Recovery is usually faster than surgical sleeve gastrectomy.

GLP-1 medications such as semaglutide and tirzepatide are injectable therapies prescribed by physicians for metabolic disease or chronic weight management.

For some patients, combining ESG with GLP-1 medication may improve weight-loss outcomes and help maintain results over time.

Clinical Approaches Doctors Use

Doctors may recommend a staged strategy. Some patients begin with ESG and later add medication if weight loss slows. Others may start GLP-1 therapy first and proceed with ESG if additional intervention is needed.

Long-term success often depends on lifestyle changes, nutritional guidance, and ongoing medical monitoring.

Learn More About: ESG Success Stories: Real Transformations and Before-After Results

When Should You See a Doctor?

A medical evaluation may help if you have struggled with weight loss despite diet and exercise. People with obesity-related conditions such as type 2 diabetes, fatty liver disease, or sleep apnea may benefit from physician-guided treatment.

Patients who have regained weight after a previous bariatric procedure should also discuss available options with a specialist.

🟨 No surgery, no hospital stay, no scars — ESG remains one of Florida’s safest and most popular minimally invasive weight loss procedures for local and visiting patients.
Schedule Your Consultation Today

Dr. Alexander Shapsis is dedicated to helping patients achieve their weight loss goals safely and effectively. To learn more about the Endoscopic Sleeve Gastroplasty (ESG) and explore your options, schedule a consultation today.

Location: 12462 West Atlantic Boulevard, Coral Springs, FL
Phone: 1-954-758-4245

FAQ